NCT01741714

Brief Summary

This study will highlight and validate chiropractic spinal manipulative therapy (CSMT) for migraine. If the method proves to be effective, it will provide a new non-pharmacological treatment option for migraine. This is especially important since some migraineurs do not tolerate acute and/or prophylactic medicine, due to side effects or contraindications due to comorbidity of other diseases while others do not have effect. Thus, alternative treatment options are warranted. The applied methodology of the study will aim towards the highest possible research standards. This international study is a collaboration between Akershus University Hospital, University of Oslo (UiO), Norway and Macquarie University, Australia. The multidisciplinary professional backgrounds are physiotherapy, chiropractic and medicine. By increasing the methodological quality of the investigators research to a very high level, the investigators see the method to work as a guide to increase the quality of chiropractic research in the future, as previous randomized clinical trials (RCTs) of migraine used methodology showing room for improvement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 2, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 5, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2013

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

January 10, 2019

Status Verified

January 1, 2019

Enrollment Period

2.1 years

First QC Date

December 2, 2012

Last Update Submit

January 9, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number og headache days

    1. 25% reduction in number of headache days between active treatment and sham. 2. 25% reduction in number of headache days between active treatment and control group.

    Change from baseline to post-treatment, 3, 6, 12 months follow-up

Secondary Outcomes (4)

  • Headache duration

    Change from baseline to post-treatment, 3, 6, 12 months follow-up

  • Self reported VAS

    Change from baseline to post-treatment, 3, 6, 12 months follow-up

  • Headache index

    Change from baseline to post-treatment, 3, 6, 12 months follow-up

  • Headache medication

    Change from baseline to post-treatment, 3, 6, 12 months follow-up

Other Outcomes (1)

  • Sub analysis on x-ray findings

    Pre-treatment

Study Arms (3)

Chiropractic Spinal Manipulative Therapy

ACTIVE COMPARATOR

Active chiropractic spinal manipulative treatment

Other: Chiropractic spinal manipulative therapy

Sham manipulation

SHAM COMPARATOR

Sham chiropractic manipulative therapy

Other: Sham chiropractic manipulative therapy

Control group

NO INTERVENTION

No intervention, follow headache diary

Interventions

Sham manipulation

Sham manipulation

Chiropractic spinal manipulative therapy

Chiropractic Spinal Manipulative Therapy

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Migraine according to the diagnostic criteria of the ICHD-II (8)
  • At least one migraine attack per month
  • Age 18-70 years

You may not qualify if:

  • Contraindication to spinal manipulation
  • Chiropractic treatment within the last 12 months
  • Radiculopathy
  • Depression
  • Pregnancy
  • Participants whom become pregnant during the migraine trial will also be excluded from analysis from the time of pregnancy
  • Participants who change their prophylactic medical regime for headaches will be excluded in the analysis from the time of change

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research Centre, Akershus University Hospital

Lørenskog, 1478, Norway

Location

Related Publications (5)

  • Chaibi A, Tuchin PJ, Russell MB. Manual therapies for migraine: a systematic review. J Headache Pain. 2011 Apr;12(2):127-33. doi: 10.1007/s10194-011-0296-6. Epub 2011 Feb 5.

    PMID: 21298314BACKGROUND
  • Chaibi A, Saltyte Benth J, Tuchin PJ, Russell MB. Chiropractic spinal manipulative therapy for migraine: a study protocol of a single-blinded placebo-controlled randomised clinical trial. BMJ Open. 2015 Nov 19;5(11):e008095. doi: 10.1136/bmjopen-2015-008095.

    PMID: 26586317BACKGROUND
  • Chaibi A, Benth JS, Tuchin PJ, Russell MB. Chiropractic spinal manipulative therapy for migraine: a three-armed, single-blinded, placebo, randomized controlled trial. Eur J Neurol. 2017 Jan;24(1):143-153. doi: 10.1111/ene.13166. Epub 2016 Oct 2.

  • Chaibi A, Saltyte Benth J, Bjorn Russell M. Validation of Placebo in a Manual Therapy Randomized Controlled Trial. Sci Rep. 2015 Jul 6;5:11774. doi: 10.1038/srep11774.

  • Chaibi A, Benth JS, Tuchin PJ, Russell MB. Adverse events in a chiropractic spinal manipulative therapy single-blinded, placebo, randomized controlled trial for migraineurs. Musculoskelet Sci Pract. 2017 Jun;29:66-71. doi: 10.1016/j.msksp.2017.03.003. Epub 2017 Mar 14.

MeSH Terms

Conditions

Migraine with AuraMigraine without Aura

Condition Hierarchy (Ancestors)

Migraine DisordersHeadache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Michael B Russell, Professor

    Head and Neck Research Group, Research Centre, Akershus University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student

Study Record Dates

First Submitted

December 2, 2012

First Posted

December 5, 2012

Study Start

February 1, 2013

Primary Completion

March 1, 2015

Study Completion

September 1, 2015

Last Updated

January 10, 2019

Record last verified: 2019-01

Locations